Stryker (SYK) has drawn fresh attention after recent price moves, with the stock showing a small gain over the past month but ...
Zacks Investment Research on MSN
Why Stryker (SYK) is a top momentum stock for the long term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Stryker (NYSE: SYK), the medical devices powerhouse, has recently launched its Sync Badge—a hands-free, wearable communication device designed to enhance collaboration among healthcare teams. This new ...
Zacks Investment Research on MSN
Stryker (SYK) earnings expected to grow: Should you buy?
The market expects Stryker (SYK) to deliver a year-over-year increase in earnings on higher revenues when it reports results ...
Stryker (NYSE:SYK) recently experienced a significant cyberattack that disrupted elements of its operations. In response, ...
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker today and set a price target of $397.00. Claim 30% Off TipRanks. Unlock hedge fund-level data and powerful investing ...
Investors in Stryker Corp (Symbol: SYK) saw new options become available today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...
The global orthopedic space has seen significant transformative changes in recent times. Major players like Stryker SYK and Zimmer Biomet ZBH have rapidly adopted differentiated strategies to make up ...
Stryker stock (NYSE: SYK) has fallen 10% in a month, while it’s down 12% in the last six months. The company recently reported its Q1 results, which were better than the street estimates. Stryker’s ...
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results